Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07290504
Recruiting
Gradual Versus Intermittent Release of Tourniquet Effect on MAP in Hypertensive Patients Undergoing Upper Limb Orthopedic Surgeries
Not applicable · Egypt · 1 site
Registry update: 5 Aug 2026
NCT07307235
Recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Phase 4 · China · 24 sites
Registry update: 7 Jul 2026
NCT07189637
Recruiting
The Combined Effect of the Mediterranean Diet and Intermittent Fasting on Hypertension
Not applicable · 1 site
Registry update: 25 Sept 2026
NCT07226856
Recruiting
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
Phase 2 · United States · 3 sites
Registry update: 2 Oct 2026
NCT07716228
Recruiting
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound
Phase 3 · China · 1 site
Registry update: 21 Jul 2026
NCT07309497
Recruiting
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
Not applicable · Switzerland · 2 sites
Registry update: 30 Dec 2025
NCT07059299
Recruiting
A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma
Phase 1 · Germany · 4 sites
Registry update: 19 Dec 2025
NCT07798700
Recruiting
Biofluid Research on Age-Related or Inherited Neurodegeneration
Not applicable · United States · 1 site
Registry update: 1 Sept 2026
NCT07221474
Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
Phase 2 · Argentina, Australia, Chile, Spain, France, Italy, South Korea, Poland, Taiwan, United States · 58 sites
Registry update: 1 Oct 2026
NCT07221188
Recruiting
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Phase 3 · Austria, Australia, Belgium, Bulgaria, Germany, Spain, France, Greece, Hong Kong, Italy, Japan, Netherlands, New Zealand, Poland, Saudi Arabia, United States · 154 sites
Registry update: 17 Sept 2026
2025-521866-92-01
Recruiting
Sonlicromanol in post-COVID: A randomized, double-blind, placebo-controlled, phase II trial
Phase 2 · Netherlands · 1 site
Registry update: 6 Nov 2026
NCT07141355
Recruiting
Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial
Not applicable · France · 1 site
Registry update: 20 Aug 2026
2025-522233-62-00
Recruiting
A study to investigate the safety and efficacy of ONA-255 in participants with advanced cancer
Phase 1/2 · Spain · 6 sites
Registry update: 19 Nov 2025
NCT07337785
Recruiting
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 12 May 2026
NCT07107529
Recruiting
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
Phase 2 · Spain, Italy, Netherlands, Norway · 29 sites
Registry update: 15 Apr 2026
NCT07189455
Recruiting
Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
Phase 3 · China · 1 site
Registry update: 5 Jan 2026
NCT07221851
Recruiting
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Phase 3 · Germany, Spain, France, Italy, South Korea, Romania, United States · 45 sites
Registry update: 30 Sept 2026
NCT06887348
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Phase 4 · Australia, Germany, Spain, France, Greece, Poland, United States · 17 sites
Registry update: 12 Jan 2026
NCT07254585
Recruiting
SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 19 Oct 2026
NCT07481058
Recruiting
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
Phase 2 · China · 1 site
Registry update: 20 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.